Two Sigma Securities’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History
Bought
Maintained
Sold
Other funds holding VAXX
BCM
SAS
Two Sigma Securities's VAXX Position: Q1 2024 in Review
Two Sigma Securities sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q1 2024, closing a stake of 11,684 shares — an estimated $9.93K sold.
Two Sigma Securities first reported a position in VAXX in Q4 2023 and held it in 1 quarter. The position peaked at $9.93K in Q4 2023. 58 funds tracked by Wall St. Rank hold VAXX as of Q1 2024.
- Two Sigma Securities reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
- Two Sigma Securities sold 11,684 Vaxxinity, Inc. Class A Common Stock shares in Q1 2024, an estimated $9.93K.
- Two Sigma Securities first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2023 and held it in 1 quarter.
- Two Sigma Securities's Vaxxinity, Inc. Class A Common Stock position peaked at $9.93K in Q4 2023.
- 58 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q1 2024.
Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.